Curaleaf Holdings, Inc. (CURLD)

↓ Download CSV

CIK 0001756770 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated A1
  • Fiscal year ends Dec 31

In fiscal 2025, Curaleaf Holdings, Inc. reported revenue of $1.27B, down 5.0% from the prior year. The company ran a net loss, with a net margin of -18.2% and a gross margin of 49.8%. It held $2.85B in total assets against $2.01B in total liabilities.

Key ratios (FY2025)

49.8%
Gross margin
2.0%
Operating margin
-18.2%
Net margin
-30.6%
Return on equity
-5.0%
Revenue growth (YoY)
Metric (FY)20252024202320222021
Revenue$1.27B$1.33B$1.35B$1.28B$1.20B
Cost of Revenue$637.11M$693.52M$732.18M$649.00M$626.16M
Gross Profit$631.02M$640.78M$614.45M$626.42M$569.83M
Operating Income$25.45M$24.74M$42.88M$64.99M$58.57M
Net Income-$231.07M-$215.42M-$281.20M-$370.10M-$205.94M
EPS (Diluted)$-0.35$-0.32$-0.39$-0.52$-0.29
Total Assets$2.85B$2.95B$3.10B$3.41B$3.11B
Total Liabilities$2.01B$1.96B$1.93B$2.01B$1.44B
Shareholders' Equity$756.35M$861.21M$1.05B$1.28B$1.55B
Cash & Equivalents$163.18M$299.33M
Operating Cash Flow$137.71M$163.62M$75.26M$46.40M-$58.28M
Capital Expenditures$63.44M$92.44M$65.45M$134.64M$171.96M
Shares Outstanding762.09M740.83M724.12M711.16M698.76M